Transfusion-associated graft versus host disease (TAGVHD) – with reference to neonatal period

References

• Sebnem Kilic S, Kavurt S, Balaban Adim S. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency. J Investig Allergol Clin Immunol 2010;20:153–6
   PubMed Web of Science ®Google Scholar
• Schroeder ML. Review-transfusion-associated graft-versus-host disease. Br J Haematol 2002;117:275–87
   PubMed Web of Science ®Google Scholar
• Dwyre DM, Holland PV. Transfusion-associated graft-versus-host disease. Vox Sanguinis 2008;95:85–93
   PubMed Web of Science ®Google Scholar
• Australian and New Zealand Society of Blood Transfusion Ltd. 1st ed, January 2011:8. Guidelines for prevention of transfusion-associated graft-versus-host disease (TA-GVHD) (Update of the Guidelines for Gamma Irradiation of Blood Components May 2003)
   Google Scholar
• Shivdasani RA, Anderson KC. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease. Leuk Lymphoma 1994;15:227–34
   PubMed Web of Science ®Google Scholar
• Sohi I, Jacob S. Transfusion associated GVHD. Ind J Pediatr 2005;72:531–4
   Google Scholar
• Tanaka K, Aki T, Shulman HM, et al. Two cases of transfusion-associated graft-vs-host disease after open heart surgery. Arch Dermatol 1992;128:1503–6
   Google Scholar
• Appleton AL, Sviland L, Pearson ADJ, et al. Diagnostic features of transfusion associated graft versus host disease. JT Clin Pathol 1994;47:541–6
   Google Scholar
• Sage D, Stanworth S, Turner D, Navarrete C. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis. Transfus Med 2005;15:481–5
   Google Scholar
• Loren D. Fast developments in the prevention of transfusion-associated graft-versus-host disease. Br J Haematol 2012;158:563–8
   Google Scholar
• Clare T, Cristina N, Marcela C. Immunological complications of blood transfusion transfusion. Alter Transfusion Med 2008;10:112–26
   Google Scholar
• Woods WG, Lubin BH. Fatal graft-versus host disease following a blood transfusion in a child with neuroblastoma. Pediatrics 1981;67:217–21
   PubMed Web of Science ®Google Scholar
• Ahya R, Douglas JG, Watson HG. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting. Heart 1998;80:299–300
   PubMed Web of Science ®Google Scholar
• Shivdasani RA, Anderson KC. Transfusion-associated graft-versus-host disease: scratching the surface. Transfusion 1993;33:696–7
   PubMed Web of Science ®Google Scholar
• Ohto H, Anderson KC. Post transfusion graft versus- host disease in Japanese newborns. Transfusion 1996;36:117–23
   PubMed Web of Science ®Google Scholar
• van de Mast Bj, Hornstra N, Ruigrok MB, et alTransfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism. Lancet 1994;343:753–7
   Google Scholar
• Sheehan T, McLaren KM, Brettle R, Parker AC. TAGVHD in an apparently healthy 22-year-old woman-Transfusion-induced graft versus host disease in pregnancy. Clin Lab Haematol 1987;9:205–7
   PubMedGoogle Scholar
• Mori S, Matsushita H, Ozaki K, et al. Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 1995;35:431–5
   PubMed Web of Science ®Google Scholar
• Joel M. Rappeport-transfusion-associated graft-versus-host disease. Yale J Biol Med 1990;63:445–54
   Google Scholar
• Tamaki S, Ichinohe T, Matsuo K, et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant 2001;28:375–80
   PubMed Web of Science ®Google Scholar
• Fast LD, Nevola M, Tavares J, et al. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease. Transfusion 2013;53:373–81
   PubMed Web of Science ®Google Scholar
• Strauss RG, Johnson K, Cress G, Cordle DG. Alloimmunization in preterm infants after repeated transfusions of WBC-reduced RBCs from the same donor. Transfusion 2000;40:1463–8
   Google Scholar
• Kliegman B, Hal B, eds. Nelson text book of paediatrics, 18th ed. Elsevier South Asia Edition. Philadelphia (PA): Saunders-An Imprint of Elsevier; 2008:552–3 and 873–7
   Google Scholar
• Déroche A, Piazzon I, Nepomnaschy I, Pasqualini CD. Neonatal cells in the immunoregulation of parental alloreactivity. J Reprod Immunol 1987;10:121–32
   PubMed Web of Science ®Google Scholar
• Fauci, Braunwald, Isselbacher, et al., eds. Harrison's principles of internal medicine – international edition, 14th ed. New York: McGraw Hill-Health Professions Division; 1998:1760–2
   Google Scholar
• Somerset DA, Zheng Y, Kilby MD, et al. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004;112:38–43
   PubMed Web of Science ®Google Scholar
• Tilburgs T, Roelen DL, van der Mast BJ, et al. Differential distribution of CD 4 (+) CD 25 (bright) and CD 8 (+) CD 28 (−) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006;27:47–53
   PubMed Web of Science ®Google Scholar
• Zenclussen ML, Thuere C, Ahmad N, et al. The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am J Reprod Immunol 2010;63:200–8
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iwatani Y, Kaneda T, et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997;37:368–77
   PubMed Web of Science ®Google Scholar
• Picchiassi E, Coata G, Centra M, et al. Identification of universal mRNA markers for noninvasive prenatal screening of trisomies. Prenatal Diagn 2010;30:764–70
   PubMed Web of Science ®Google Scholar
• Jiang S-P, Vacchio MS. Cutting edge: multiple mechanisms of peripheral ‘T’ cell tolerance to the fetal “allograft”. J Immunol 1998;160:3086–90
   PubMed Web of Science ®Google Scholar
• Sloan SR. Neonatal transfusion review. Paediatr Anaesth 2011;21:25–30
   PubMed Web of Science ®Google Scholar
• van Royen Kerkhof A, Wulffraat NM, Kamphuis SSM, et al. Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient. Bone Marrow Transpl 2003;32:1027–30
   Google Scholar
• Gokhale SG, Ranadive M, Chouhan R, Gokhale S. Maternal-neonatal transfusion compatibility irrespective of ABO mismatch – a prospective observational study. J Matern Fetal Neonatal Med 2014;27:397–401
   PubMed Web of Science ®Google Scholar